Anil Vachani MD
Critical Care Medicine, Pleural Disease
Assistant Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3400 Civic Center BlvdFl 1Philadelphia, PA 19104
Phone+1 215-662-3202
Fax+1 215-349-8432
Dr. Vachani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003- University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
University of California San Francisco School of MedicineClass of 1996
Certifications & Licensure
NY State Medical License 2025 - 2027
PA State Medical License 1997 - 2026
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Early Diagnosis of Pulmonary Nodules Start of enrollment: 2012 Oct 01
- DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules Start of enrollment: 2013 Jan 01
- DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Gaps in care across the cancer screening continuum for cervical, colorectal and lung cancer.Jennifer S Haas, Kaitlin W Todd, Dale Mclerran, Jasmin A Tiro, Anil Vachani
Journal of the National Cancer Institute. 2025-09-10 - Implications of primary tumor size on overall survival in patients with multifocal T3 non-small cell lung cancer.Ravi Rajaram, Qing Huang, Barbara H Johnson, Balaji Laxmanan, Iftekhar Kalsekar
Lung Cancer. 2025-09-05 - A multivariate cell-based liquid biopsy for lung nodule risk stratification: Analytical validation and early clinical evaluation.Jason D Berndt, Fergal J Duffy, Mark D D'Ascenzo, Leslie R Miller, Yijun Qi
The Journal of Liquid Biopsy. 2025-09-01
Journal Articles
- A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CTAnil Vachani, William N Rom, Gerard Criner, Harvey Pass, Clinical Cancer Research
Press Mentions
AI Program Accurately Diagnoses Common Lung Cancer from Tissue ImagesJune 11th, 2024- Optellum's Clinical Partners Present at ATS International Conference 2023May 19th, 2023
- Penn Medicine Lands $5.7M NCI Grant for Telehealth Research CenterAugust 19th, 2022
- Join now to see all
Grant Support
- Increasing Lung cancer screening Effectiveness and Access through Regional Networks (I-LEARN)UNIVERSITY OF PENNSYLVANIA2025–2027
- Advancing cancer care and equity through telehealth, communication science, and behavioral economicsUNIVERSITY OF PENNSYLVANIA2022–2027
- Center for Research to Optimize Precision Lung Cancer Screening in Diverse PopulationsKAISER FOUNDATION RESEARCH INSTITUTE2018–2025
- Peripheral Blood Gene Expression For The Diagnosis Of Indeterminate Lung NodulesNational Cancer Institute2011
- Molecular Epidemiology Of Lung CancerNational Cancer Institute2006–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
